The Europe epilepsy devices market is predicted to propel with a 7.61% CAGR by 2030, anticipated to generate $325.53 million in revenue during the assessment period 2022-2030.

EUROPE EPILEPSY DEVICES MARKET FORECAST 2022-2030

Europe Epilepsy Devices Market by Product Type (Conventional Devices, Wearable Devices, Implantable Devices) Market by Technology (Vagus Nerve Stimulation, Deep Brain Stimulation, Accelerometry, Responsive Neurostimulation) Market by Detection & Prediction Devices Type (Electroencephalogram, Intracranial Eeg, Surface Electromyography, Electrocardiography, Video Detection Systems, Electrodermal Activity, Implanted Advisory Systems, Other Detection & Prediction Device Types) Market by End-user (Hospitals & Clinics, Neurology Centers, Home Care Settings, Other End-users) By Geography

Request free sample

Report Summary

The Europe epilepsy devices market is predicted to propel with a 7.61% CAGR by 2030, anticipated to generate $325.53 million in revenue during the assessment period 2022-2030.

The Europe epilepsy devices market is estimated to surge owing to reimbursement availability, a growing geriatric population prone to epilepsy, and technological advancements in therapeutic devices. Furthermore, the presence of highly developed healthcare infrastructure and research funds from governmental organizations are expected to positively impact the epilepsy devices market in the region. Also, there is a higher risk of epilepsy for older people. Hence, the growing geriatric population is a driving factor for the Europe epilepsy devices market.

Europe Epilepsy Devices Market

To know more about this report, request a free sample copy

The Europe epilepsy devices market growth analysis entails a focused study of Nordic Countries, United Kingdom, Spain, France, Germany, Italy, and Rest of Europe. In the United Kingdom, many young people with epilepsy are more likely to experience behavioral and mental health issues in addition to seizures. Given that young individuals with epilepsy are expected to be a particularly vulnerable group in terms of the emergence of, or aggravation of, pre-existing mental health and behavior disorders, such variables are anticipated to increase the sales of epilepsy devices in the United Kingdom.

On the other hand, the foundation of the German healthcare system is a large pool of specialists and general practitioners, such as privately practiced neurologists. Specialized hospital outpatient clinics, such as specialized epilepsy centers, offer the third level of outpatient medical care and act as the primary provider for seriously ill patients.

The Epilepsy Center Frankfurt Rhine-Main at the University Hospital Frankfurt (Germany) is one of the tertiary care facilities for epilepsy patients of every age. It also conducts pre-surgical analysis for drug-refractory epilepsies. The hospital has also reported a sizable epilepsy outpatient clinic with over 2500 patients attended to in a year. According to hospital reports, about 50,000 patients receive inpatient care at the University Hospital Frankfurt annually, and around 450,000 individuals receive ambulatory care.

The Europe epilepsy devices market segmentation analysis includes the market by technology, end-user, detection & prediction devices type, and product type. Market by detection & prediction devices type entails electrocardiography, surface electromyography, video detection systems, intracranial EEG, implanted advisory systems, electroencephalogram, electrodermal activity, and other detection & prediction device types.

Epilepsy patients need assistance as their life is always at risk due to convulsive seizures (CS). Therefore, automated real-time seizure detection systems help alert caregivers. Moreover, video detection systems and EEG monitoring VEM (Video EEG Monitoring) work to capture electrical activity in the brain (EEG) and patients’ behavior with specialized equipment that records EEG, sound, and video. VEMs are usually done between episodes, which helps correlate the patient’s behavior with the EEG data.

Although an increase in heart rate results in a significant number of seizures, fluctuating heart rate at the onset of epileptic seizures is often overlooked as a clinical sign. As a counter-measure, in 2022, the Food and Drug Administration (FDA) granted 510(k) clearance to Seer Home, an ambulatory electroencephalograph (EEG) system for the in-home diagnosis of epilepsy via multiday video monitoring and wirelessly transmitted data to assist physicians in the diagnosis of the neurological condition.

Some key players operating in the Europe epilepsy devices market are LivaNova PLC, NeuroPace Inc, etc.

LivaNova PLC is a global medical technology company that offers products and therapies for the head and heart. Their diverse product portfolio and pipeline include therapeutic areas such as advanced circulatory support, cardiopulmonary, difficult-to-treat depression, drug-resistant epilepsy, heart failure, and obstructive sleep apnea. The company offers solutions to patients, healthcare professionals and healthcare systems and operates across the Americas, Europe, Asia-Pacific, and the Middle East & Africa. LivaNova PLC is headquartered in London, United Kingdom.

VNS Therapy from LivaNova is a small device implanted under the skin in the chest and connected to the left vagus nerve in the neck. It is developed as an add-on neuromodulation treatment designed for people with drug-resistant epilepsy 4 years of age and older with partial onset seizures.

Report Synopsis

Report Scope	Details
Market Forecast Years	2022-2030
Base Year	2021
Market Historical Years	2018-2021
Forecast Units	Revenue ($ Million)
Segments Analyzed	Product Type, Technology, End-User, Detection & Prediction Devices Type
Countries Analyzed	United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe.
Companies Analyzed	Boston Scientific Corporation, Cadwell Industries Inc, Compumedics Limited, Drägerwerk AG & Co KGaA, Empatica Inc, Koninklijke Philips NV, LivaNova PLC, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NeuroPace Inc, Neurosoft, Shenzhen Mindray Bio-Medical Electronics Co Ltd

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- KEY DRIVERS
  - SOARING OCCURRENCES OF EPILEPSY GLOBALLY
  - ONSET OF EPILEPSY IN ELDERLY PEOPLE
  - MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
  - SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
- KEY RESTRAINTS
  - MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
  - SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

KEY ANALYTICS
- IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - BUYERS POWER
  - SUPPLIERS POWER
  - SUBSTITUTION
  - NEW ENTRANTS
  - INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
  - COMFORT & USABILITY
  - PRODUCT FEATURES
  - CONFIDENTIALITY
- REGULATORY FRAMEWORK
MARKET BY PRODUCT TYPE
- CONVENTIONAL DEVICES
- WEARABLE DEVICES
  - WATCHES
  - BRACELETS
  - CAMERA DEVICES
  - MATTRESS DEVICES
  - ANTI-SUFFOCATION PILLOWS
  - OTHER WEARABLE DEVICES
- IMPLANTABLE DEVICES
MARKET BY TECHNOLOGY
- VAGUS NERVE STIMULATION
- DEEP BRAIN STIMULATION
  - MOVEMENT DISORDERS
  - EPILEPSY
- ACCELEROMETRY
- RESPONSIVE NEUROSTIMULATION
MARKET BY DETECTION & PREDICTION DEVICES TYPE
- ELECTROENCEPHALOGRAM
- INTRACRANIAL EEG
- SURFACE ELECTROMYOGRAPHY
- ELECTROCARDIOGRAPHY
- VIDEO DETECTION SYSTEMS
- ELECTRODERMAL ACTIVITY
- IMPLANTED ADVISORY SYSTEMS
- OTHER DETECTION & PREDICTION DEVICE TYPES
MARKET BY END-USER
- HOSPITALS & CLINICS
- NEUROLOGY CENTERS
- HOME CARE SETTINGS
- OTHER END-USERS
GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - UNITED KINGDOM
    - GERMANY
    - FRANCE
    - ITALY
    - SPAIN
    - NORDIC COUNTRIES
    - REST OF EUROPE

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS
- COMPANY PROFILES
  - BOSTON SCIENTIFIC CORPORATION
  - CADWELL INDUSTRIES INC
  - COMPUMEDICS LIMITED
  - DRÄGERWERK AG & CO KGAA
  - EMPATICA INC
  - KONINKLIJKE PHILIPS NV
  - LIVANOVA PLC
  - MEDTRONIC PLC
  - NATUS MEDICAL INCORPORATED
  - NEUROPACE INC
  - NEUROSOFT
  - NIHON KOHDEN CORPORATION
  - SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD

LIST OF TABLES

TABLE 1: EUROPE MARKET SNAPSHOT – EPILEPSY DEVICES

TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES

TABLE 3: EXAMPLES OF MOBILE EEG DEVICES

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: EUROPE EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: EUROPE EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: EUROPE EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: EUROPE EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: LEADING PLAYERS OPERATING IN EUROPE EPILEPSY DEVICES MARKET

TABLE 20: LIST OF ACQUISITIONS

TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 22: LIST OF PARTNERSHIPS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 8: EUROPE EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 9: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 10: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021

FIGURE 11: EUROPE EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)

FIGURE 12: EUROPE EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)

FIGURE 13: EUROPE EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 14: EUROPE EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 15: EUROPE EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)

FIGURE 16: EUROPE EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 17: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 18: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 19: EUROPE EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 20: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 21: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021

FIGURE 22: EUROPE EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 23: EUROPE EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)

FIGURE 24: EUROPE EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)

FIGURE 25: EUROPE EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 26: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021

FIGURE 27: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)

FIGURE 28: EUROPE EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)

FIGURE 29: EUROPE EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 30: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 31: EUROPE EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 32: EUROPE EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)

FIGURE 33: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 34: EUROPE EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICES TYPES, 2022-2030 (IN $ MILLION)

FIGURE 35: EUROPE EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 36: EUROPE EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)

FIGURE 37: EUROPE EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 38: EUROPE EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)

FIGURE 39: EUROPE EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 40: EUROPE EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 41: UNITED KINGDOM EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: GERMANY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: FRANCE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: ITALY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: SPAIN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: NORDIC COUNTRIES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: REST OF EUROPE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - UNITED KINGDOM
    - GERMANY
    - FRANCE
    - ITALY
    - SPAIN
    - NORDIC COUNTRIES
    - REST OF EUROPE

MARKET BY PRODUCT TYPE
- CONVENTIONAL DEVICES
- WEARABLE DEVICES
  - WATCHES
  - BRACELETS
  - CAMERA DEVICES
  - MATTRESS DEVICES
  - ANTI-SUFFOCATION PILLOWS
  - OTHER WEARABLE DEVICES
- IMPLANTABLE DEVICES
MARKET BY TECHNOLOGY
- VAGUS NERVE STIMULATION
- DEEP BRAIN STIMULATION
  - MOVEMENT DISORDERS
  - EPILEPSY
- ACCELEROMETRY
- RESPONSIVE NEUROSTIMULATION
MARKET BY DETECTION & PREDICTION DEVICES TYPE
- ELECTROENCEPHALOGRAM
- INTRACRANIAL EEG
- SURFACE ELECTROMYOGRAPHY
- ELECTROCARDIOGRAPHY
- VIDEO DETECTION SYSTEMS
- ELECTRODERMAL ACTIVITY
- IMPLANTED ADVISORY SYSTEMS
- OTHER DETECTION & PREDICTION DEVICE TYPES
MARKET BY END-USER
- HOSPITALS & CLINICS
- NEUROLOGY CENTERS
- HOME CARE SETTINGS
- OTHER END-USERS